Research Team

Matthew L. Kaplan

Managing Director, Healthcare Research

mkaplan@ladenburg.com

Mr. Kaplan has 14 years of experience as a biotechnology analyst. His current research focus is therapeutic companies, cardiovascular, and drug delivery. Prior to joining Ladenburg Thalmann, he was a Partner and the Director of Healthcare Research with Punk, Ziegel & Company. Previously, he was a Senior Biotechnology Analyst at Evolution Capital and a Director of The Life Sciences Group at The Carson Group. Before joining The Carson Group and Evolution Capital, Mr. Kaplan had six years of experience as a Research Associate with the Albert Einstein College of Medicine/Montefiore Hospital Department of Cardiology. Mr. Kaplan received his bachelor’s degree in Biology from the University of Michigan and studied Cellular and Molecular Biology at Columbia University.

Healthcare & Life Sciences

Jeffrey S. Cohen

Jeffrey S. Cohen

Director of Research | Managing Director, Equity Research Healthcare & Medical Technologies

Destiny Hance

Destiny Hance

Associate Director of Research

Matthew L. Kaplan

Matthew L. Kaplan

Managing Director, Healthcare Research

Aydin Huseynov, M.D., CFA

Aydin Huseynov, M.D., CFA

Managing Director, Biotechnology Equity Research

Yield-Oriented Equities

Mickey M. Schleien, CFA

Mickey M. Schleien, CFA

Managing Director, Equity Research

Christopher Nolan, CFA

Christopher Nolan, CFA

Executive Vice President, Equity Research

Energy, Power & Infrastructure

Paul Fremont

Paul Fremont

Managing Director

Telecom, Media & Technology

Jon R. Hickman

Jon R. Hickman

Managing Director, Equity Research

Glenn G. Mattson, Jr.

Glenn G. Mattson, Jr.

Vice President, Equity Research